Skye Bioscience, Inc. (SKYE)
1.14
-0.07
(-5.79%)
USD |
NASDAQ |
Dec 10, 16:00
1.16
+0.02
(+1.75%)
After-Hours: 20:00
Skye Bioscience EPS Diluted (Quarterly): -0.3216 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Perspective Therapeutics, Inc. | -0.3495 |
| Theravance Biopharma, Inc. | 0.0696 |
| Viking Therapeutics, Inc. | -0.8083 |
| FibroGen, Inc. | 36.71 |
| Myomo, Inc. | -0.0869 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -12.75M |
| Total Expenses (Quarterly) | 12.75M |
| Enterprise Value | 1.555M |
| Earnings Yield | -113.1% |
| Normalized Earnings Yield | -115.73 |